Felix Biotech

Phaxiam

The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.

BiomX

This clinical-stage biotechnology company develops natural and engineered bacteriophage cocktails to treat chronic bacterial infections and inflammatory diseases for healthcare providers and patients.

Phagos

The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.

Locus Biosciences

This biotechnology company develops engineered bacteriophage therapies for patients with drug-resistant bacterial infections using CRISPR technology and artificial intelligence.

Telum Therapeutics

Telum Therapeutics develops engineered phage lytic proteins to treat multidrug-resistant bacterial infections for patients with hospital-acquired and ventilator-associated pneumonia.

Clarametyx Biosciences

This company develops immune-enabling therapies targeting bacterial biofilms for patients with chronic and progressive respiratory diseases.

Ancilia Bio

The company develops CRISPR-engineered bacterial therapies with viral immunity for the biopharmaceutical and healthcare sectors.

PhageLab

PhageLab develops bacteriophage treatments to control bacterial pathogens in livestock and poultry production, reducing the industry's reliance on antibiotics.